| Allison Reeves Granger, | |
|
1982 N Railroad Ave, Arcadia, LA 71001-3422 | |
| (318) 263-2919 | |
| (318) 263-9819 |
| Full Name | Allison Reeves Granger |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1982 N Railroad Ave, Arcadia, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801484563 | NPI | - | NPPES |
| PST.017736 | Other | LA | LOUISIANA BOARD OF PHARMACY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PST.017736 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Allison Reeves Granger, 1982 N Railroad Ave, Arcadia, LA 71001-3422 Ph: (318) 263-2919 | Allison Reeves Granger, 1982 N Railroad Ave, Arcadia, LA 71001-3422 Ph: (318) 263-2919 |
News Archive
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris for the development of a therapy for type 1 diabetes.
The Washington Post on Sunday examined how hospitals across the U.S. have begun addressing nursing shortages "by introducing technology to dramatically reduce paperwork, offering more flexible hours, reducing caseloads, paying for advanced training and giving [nurses] more authority" instead of using financial incentives to lure nurses.
As part of the $5 billion in grants announced by President Obama, the National Institutes of Health has granted Kaiser Permanente more than $54 million over two years through the American Recovery and Reinvestment Act to conduct health research on a multitude of critical public and clinical health areas.
GTx, Inc. today reported financial results for the second quarter of 2010. The net loss for the quarter ended June 30, 2010 was $12.9 million compared with a net loss of $11.3 million for the quarter ended June 30, 2009. The net loss for the second quarter of 2010 included a $1.7 million non-cash impairment charge related to the conclusion of the Phase III clinical trial of toremifene 20 mg.
The recent report by the U.S. Centers for Disease Control and Prevention (CDC) published in JAMA Pediatrics, highlights the rising prevalence of prediabetes, which can lead to type 2 diabetes if it's not treated or controlled early. In the country, an estimated 18 percent among adolescents between the ages of 12 and 18, and 24 percent among young adults, between 19 and 34 have prediabetes.
› Verified 4 days ago
Jesse Eugene Reeves Iii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1982 N Railroad Ave, Arcadia, LA 71001 Phone: 318-263-2919 Fax: 318-263-9819 | |
Mr. Steve Burke Cole, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1311 Hazel St, Arcadia, LA 71001 Phone: 318-263-3948 | |
Dr. Maegan Griggs Sylvester, PHD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1311 Hazel St, Arcadia, LA 71001 Phone: 318-263-9160 | |
Sarah Ann Hall, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1311 Hazel St, Arcadia, LA 71001 Phone: 318-263-3948 | |
James Vessel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1311 Hazel St, Arcadia, LA 71001 Phone: 318-263-3948 |